The research team, led by Jessica S. Johnson of the Department of Psychiatry at the University of North Carolina at Chapel Hill, together with colleagues including Cynthia M. Bulik of the University of North Carolina and Karolinska Institutet, and Melissa A. Munn-Chernoff of Texas Tech University, analyzed data from the United States arm of the global Eating Disorders Genetics Initiative, known as EDGI. This initiative, funded by the National Institute of Mental Health, is one of the largest genetic studies of eating disorders ever undertaken and is registered as a clinical trial. From this resource, the investigators assembled a cohort of 6,128 participants, 95 percent of whom were female, with a mean age of 34.9 years.

What distinguished this study from prior work was its systematic comparison of nicotine use patterns across the full diagnostic spectrum of eating disorders. Participants fell into six groups based on lifetime diagnoses: anorexia nervosa only, which accounted for 37 percent of the sample; anorexia nervosa plus another eating disorder, at 21 percent; bulimia nervosa only, at 11 percent; bulimia nervosa combined with binge-eating disorder, at 14 percent; binge-eating disorder only, at 10 percent; and a comparison group of screened controls with no lifetime eating disorder diagnosis and no history of eating disorder behaviors, representing 7 percent of the cohort. This diagnostic granularity allowed the researchers to test not only whether eating disorders in general are linked to nicotine use, but whether specific diagnoses carry different risk profiles.

Each participant reported whether they had ever used nicotine, and the investigators classified them into four categories: never used nicotine, which comprised half the sample; vaped only, which accounted for 6 percent; smoked only, at 22 percent; and combined vaping plus smoking, which also represented 22 percent. Notably, nearly half of the cohort reported some form of lifetime nicotine use, a proportion that immediately stands out against the backdrop of declining smoking rates in the general population.

The statistical approach was carefully constructed to handle the large number of comparisons being made. The team used chi-square tests to examine categorical associations, analysis of variance to compare continuous measures across groups, and multinomial logistic regression to estimate the odds of belonging to each nicotine use category as a function of eating disorder diagnosis and symptom profile. Because the study tested many associations simultaneously, the researchers applied false discovery rate correction, a method that controls the expected proportion of false positives among statistically significant findings. Even under this stringent correction, the results were robust: lifetime nicotine use was significantly more common among every eating disorder group than among the screened controls, with corrected p values below 8.63 × 10⁻³.

The pattern of associations across diagnoses proved to be highly informative. Compared with participants whose only lifetime diagnosis was anorexia nervosa, those with bulimia nervosa only, anorexia nervosa plus another eating disorder, or bulimia nervosa combined with binge-eating disorder showed significantly higher odds of smoking, or of combined smoking and vaping, with corrected p values below 3.79 × 10⁻³. In other words, individuals whose illness included binge-eating episodes or features of more than one diagnostic category were the most likely to report cigarette smoking or dual use of both cigarettes and e-cigarettes. Vaping alone, however, told a somewhat different story: it was reported by only 6 percent of the sample, making it a less common pattern than smoking or dual use, yet still a meaningful one given the relative novelty of electronic cigarettes and the open question of whether they serve as an entry point to nicotine dependence among people vulnerable to eating disorders.

Perhaps the most clinically striking findings emerged when the researchers turned from diagnoses to specific behaviors. Eating disorder psychopathology is characterized by a set of recurrent behaviors, including binge eating and a range of compensatory actions intended to counteract perceived weight gain: self-induced vomiting, laxative misuse, diuretic misuse, diet pill use, fasting, and excessive exercise. The team examined how each of these behaviors related to nicotine use patterns. Binge eating and every compensatory behavior except excessive exercise were significantly associated with higher odds of lifetime smoking or dual use compared with never using nicotine, with corrected p values below 7.85 × 10⁻⁴. Purging, in particular, was linked to a greater likelihood of any lifetime nicotine use whatsoever, with a corrected p value below 0.017.

The selective exception of excessive exercise is noteworthy. Exercise is unique among eating disorder compensatory behaviors in that it does not involve the ingestion of any substance, and the finding suggests that the relationship between nicotine use and eating disorder pathology may be tied to behaviors that involve manipulating what enters the body, rather than to the overall severity of the illness. One plausible mechanism is appetite suppression. Nicotine is a well-documented anorectic agent that acts on central appetite-regulating circuits, and individuals who restrict their intake, binge, or purge may use nicotine, consciously or not, as a tool for weight and appetite control. The finding that purging was linked to any nicotine use, while binge eating and most compensatory behaviors were linked specifically to smoking and dual use, hints at a complex interplay between the pharmacological effects of nicotine and the behavioral repertoire of the eating disorder.

The study’s authors are careful to note that their data are cross-sectional, meaning that they capture associations at a single point in retrospective reporting and cannot establish whether nicotine use preceded, followed, or developed alongside the eating disorder. The cohort is also predominantly female, reflecting the demographic composition of the eating disorder patient population but limiting generalizability to male and gender-diverse individuals, who represent a significant and growing share of eating disorder cases. In addition, all data were self-reported, and participants were recruited through a genetics initiative, which may influence the representativeness of the sample. These limitations notwithstanding, the sheer size of the cohort and the rigor of the statistical corrections give the findings considerable weight.

The implications for clinical practice are direct and actionable. The authors conclude that clinicians working with patients who have or are at risk for eating disorders should routinely assess not only cigarette smoking but also vaping, and should consider how nicotine use is interrelated with eating disorder pathology rather than treating it as a separate, incidental habit. This matters because nicotine use is a modifiable risk factor, and because the health consequences of smoking and vaping compound the already serious medical complications of eating disorders, including cardiovascular strain, electrolyte disturbances, and bone density loss. For a patient using laxatives, inducing vomiting, or fasting while also vaping heavily, the cumulative physiological burden may be greater than either behavior alone would suggest.

The study also arrives at a moment when vaping among young people continues to be a major public health concern, and when the eating disorder field is increasingly attentive to the roles of substances, from alcohol to stimulants, in the initiation and maintenance of disordered eating. By showing that vaping is not merely a harmless social behavior in this population, but part of a broader pattern of lifetime nicotine use that clusters with bulimic presentations and purging behaviors, the research adds urgency to the call for integrated screening. As electronic cigarette use evolves and new nicotine products reach the market, understanding how these products intersect with psychiatric conditions such as eating disorders will be essential for protecting one of the most medically vulnerable populations in mental health care.

The essence of these devices lies in their ability to convert a liquid solution—often containing nicotine and various flavoring agents—into an inhalable aerosol or vapor. They deliver hundreds to thousands of puffs per unit, making them highly popular among a broad demographic, including adolescents and young adults. The simplicity and affordability of disposables have accelerated their market penetration, yet this convenience may come at a significant biological cost. The study raises urgent questions regarding the safety profile of such products, particularly when used regularly over extended periods.

One of the most alarming findings from the research relates to the emission of heavy metals and metalloids, including lead, nickel, chromium, and antimony, from disposable e-cigarettes. While early refillable devices were known to release metals via the heating coil, the disposables demonstrated an unexpected increase in toxic elemental output as the number of puffs increased. This revelation suggests that the materials and construction of disposable devices could be an overlooked source of harmful exposure, with contaminant levels sometimes surpassing those of conventional tobacco cigarettes.

The investigative team meticulously analyzed seven popular disposable e-cigarette models from three distinct brands, deliberately including variations with light and heavy flavor additives to account for potential influences from flavoring agents on metal content. Initial assessments of unopened liquids indicated generally low concentrations of ionic metals; however, some fluids surprisingly exhibited elevated levels of lead and antimony even before use. This hinted at contamination originating not from the e-liquid solution itself but from the device’s internal components.

Subsequent scrutiny identified leaded copper alloys embedded in non-heating parts of the disposable devices as a major contributor to lead contamination in the e-liquid. These metallic parts, rather than heating elements, leached hazardous metals into the solution over time. The specific source of antimony remained ambiguous, highlighting the complexity of tracing toxic element pathways within these relatively simple-looking devices. This unexpected discovery amplifies the need for rigorous product design and materials oversight.

As the disposable devices were activated and used to generate vapor, the researchers collected and analyzed emissions over the course of 500 to 1500 puffs—simulating the span of typical consumer usage. Notably, the concentrations of certain metals such as chromium, nickel, and antimony incrementally increased with ongoing exposure, indicating a cumulative release process linked to device operation. Contrarily, zinc, copper, and lead emissions were initially elevated but did not show the same consistent escalation with additional puffs, possibly due to differential wear or leaching dynamics within the device architecture.

When these results were compared against emissions from earlier refillable e-cigarettes and traditional cigarettes, the disposable vapes frequently exhibited higher levels of toxic metals in their vapors. This suggests that popular disposable brands subject users to greater metal exposure, increasing the likelihood of adverse health effects. The fact that one device released more lead during a single day’s use than the combined total of nearly 20 packs of regular cigarettes is especially disconcerting, challenging conventional thinking about the relative safety of vaping.

Beyond simple quantification, the study also incorporated toxicological risk assessments based on the specific chemical forms of these metals. Chromium was found solely in its trivalent Cr(III) state—a form generally considered less harmful—while antimony was detected as a mixture of the less toxic pentavalent Sb(V) and the more carcinogenic trivalent Sb(III). The presence of both forms raises concerns about cumulative biological effects from repeated exposure. Moreover, the levels of nickel and Sb(III) in vapor from some disposable products exceeded thresholds associated with an increased cancer risk, while emissions of nickel and lead from other devices crossed limits relevant to non-cancerous health issues, including respiratory and neurological diseases.

Despite testing only three brands out of nearly one hundred available on the market, the implications of this study are far-reaching. Disposables have swiftly become the most prevalent category of vaping devices, especially among younger populations who may be unaware of the toxicological dangers lurking in their colorful exteriors. The ease of use, low cost, and stealth appeal of these products potentially mask a significant public health challenge that demands immediate regulatory attention, stringent quality controls, and enhanced consumer education.

The study underscores a broader concern about the regulatory landscape governing disposable e-cigarettes. Unlike many refillable products, disposables often escape rigorous marketing authorization by authorities such as the U.S. Food and Drug Administration. This regulatory gap enables devices with questionable construction and unverified ingredient safety to flood the market, complicating efforts to protect vulnerable groups. Ensuring product transparency, safety testing, and consistent oversight is critical to mitigating the rising health risks associated with these rapidly proliferating devices.

Scientifically, this research pushes forward the understanding of vaping-related toxicology by highlighting the importance of device material composition and mechanical lifecycle in determining user exposure to harmful substances. Metals leached from device components, rather than just from the liquid formulation, may constitute a hidden hazard that had been underestimated previously. Such findings call for more comprehensive studies of e-cigarette design features and their interactive effects on vapor chemistry and toxicity profiles.

From a public health perspective, there is an urgent need to communicate these findings in accessible terms to both policymakers and consumers. The elevated release of known carcinogens and neurotoxins in disposable vape aerosol engenders risk profiles that could rival or surpass those associated with combustible tobacco use. This challenges widely held perceptions of vaping as a safer alternative and calls for reconsideration of harm-reduction strategies employed by health authorities worldwide.

Overall, the study reveals a complicated interplay of engineering, chemistry, and human behavior converging to influence the safety of a technology that has captured mass appeal. Disposable e-cigarettes’ convenience and affordability come with hidden costs that current consumers may not fully grasp. As the vaping landscape continues to evolve, robust multidisciplinary research efforts will be vital to guide effective regulation, product innovation, and public health messaging aimed at minimizing preventable harm.

ACS Central Science published this rigorous investigation on June 25, 2025, providing a timely and critical contribution to the ongoing discourse around vaping safety. With the global community’s growing focus on adolescent health and nicotine addiction, these data serve as a clarion call for intensified scientific scrutiny and proactive policy responses concerning disposable e-cigarette products.

Subject of Research: Elevated toxic element emissions and health risks associated with popular disposable electronic cigarettes.

Article Title: “Elevated Toxic Element Emissions from Popular Disposable E‑Cigarettes: Sources, Life Cycle, and Health Risks”

News Publication Date: 25-Jun-2025

References: DOI: 10.1021/acscentsci.5c00641

Keywords

Chemistry, Public health, Metals

The study reveals that while regulations on flavored e-cigarettes effectively contributed to a decline in vaping rates among young adults, these very restrictions inadvertently fueled a resurgence in traditional cigarette smoking within the same demographic. This finding underscores the complexity of health policies, suggesting that efforts designed to promote healthier choices can paradoxically result in increased risks associated with more dangerous products. The implications of this research are particularly significant for public health professionals who aim to devise effective regulations against smoking.

Professor Michael Pesko, an economist at the University of Missouri, has highlighted the importance of being aware of unintended consequences that can stem from well-meaning public health policies. He notes that in moving individuals away from flavored e-cigarettes, which are often perceived as less harmful, there is a marked tendency for these smokers to revert to cigarettes, which present much greater health hazards. Pesko eloquently compares this policy misstep to steering a ship away from a storm only to plunge headfirst into a whirlpool — a vivid metaphor illustrating the dangers of neglecting the broader impact of regulatory decisions.

The study analyzed the effect of flavored e-cigarette sales restrictions across various states and concluded that, in states imposing these regulations, a noticeable increase in cigarette consumption among young adults was observable. The findings compel policymakers to rethink their strategies and consider a wider array of options that prevents youth smoking without provoking a shift back to traditional cigarettes. This scenario points to an urgent need for more sophisticated regulatory measures that do not simply ban products outright, but allow for flexibility, as evidenced by contrasting outcomes in states like Maryland.

Maryland enacted a nuanced policy wherein menthol-flavored e-cigarettes remained legal, while other flavored products faced restrictions. The results of this approach were promising; both e-cigarette and cigarette usage among young adults fell within the state. The Maryland example illustrates a critical insight: a balanced regulatory strategy may be far more effective in addressing public health concerns than blanket bans on certain products. Such strategies can potentially lead to a comprehensive reduction in overall tobacco usage, aligning closely with public health goals.

The origins of the vaping trend can be traced back to around 2010 when e-cigarettes entered the consumer market with great fanfare. Young adults quickly gravitated towards these products due to their perceived safety and variety of flavors. Pesko’s initial research trajectory was inspired by the rapid rise of e-cigarettes during his tenure at the Centers for Disease Control and Prevention. His ongoing work reflects a commitment to unraveling the intricate relationship between public health, law, and economics.

Pesko joined the University of Missouri’s faculty in August 2023, drawn by the prospect of collaborating within a prestigious economics department and benefiting from substantial university resources aiding research endeavors. His previous academic affiliations include esteemed positions at Weill Cornell Medical College and Georgia State University. At Mizzou, Pesko is leveraging advanced computational tools like Hellbender, a high-performance supercomputer, to conduct in-depth analyses of large datasets that yield actionable insights into public health impacts.

In contemplating the findings of the study published in the JAMA Health Forum, it becomes clear that any policy shaped to alter consumer behavior must also take into account the overall tobacco landscape. As heightened awareness of the dangers of smoking continues to evolve, reliance on a singular approach focusing on product bans may be misguided. Instead, a multifaceted strategy that strikes a balance between availability and public health advocacy could foster healthier choices among consumers.

The broader implications of initiatives targeting tobacco products cannot be overlooked. Public health campaigns that educate individuals regarding the relative harm of various tobacco products, combined with intelligent regulatory frameworks, can reshape perceptions and consumption habits over time. With this, the objective of promoting wellness and minimizing tobacco-related disease and death becomes increasingly attainable.

As e-cigarette usage continues to permeate social and cultural norms, understanding this intricate tapestry of consumer behavior and regulatory response is essential for healthcare advocates, policymakers, and researchers alike. The trajectory of vaping and smoking habits among young adults remains a dynamic and evolving subject that warrants continuous examination. Future research should focus on fostering interdisciplinary collaborations, merging insights from economics, public policy, and health sciences to cultivate effective solutions to reduce tobacco-related harms across demographics.

In an era of ever-evolving social norms and health challenges, the importance of informed policy-making based on comprehensive research findings cannot be overstated. As institutional frameworks grapple with these issues, a commitment to understanding the complexities of consumer behavior and the impacts of regulatory measures will prove vital for the future of public health initiatives. Ultimately, the goal remains clear — to navigate the turbulent waters of tobacco use toward a future of improved health outcomes and a reduction in preventable diseases.

—

Subject of Research: Young adult tobacco use in relation to flavored e-cigarette sales restrictions
Article Title: Flavored e-cigarette sales restrictions and young adult tobacco use
News Publication Date: 27-Dec-2024
Web References: http://dx.doi.org/10.1001/jamahealthforum.2024.4594
References: Funded by the National Institutes of Health, the U.S. Food & Drug Administration Center for Tobacco Products, and the National Institute on Drug Abuse.
Image Credits: Not applicable.

Keywords: E-cigarettes, Vaping, Public health, Tobacco policy, Young adults, Cigarette smoking, Flavor bans, Health economics, Regulation, Disease prevention, Tobacco control, Health behavior.